Clearside Biomedical
+$0.11 (+1.96%) Today
+$0.04 (+0.70%) As of 12:00 AM UTC after-hours
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CLSD and other ETFs, options, and stocks.
About CLSD
Clearside Biomedical, Inc. is a biopharmaceutical company, which engages in the development of drug therapies to treat blinding diseases of the eye. Its pipeline includes Suprachoroidal CLS-TA, Suprachoroidal, Suprachoroidal CLS-TA, and gene therapy.
CEO
George M. Lasezkay
Employees
33
Headquarters
Alpharetta, Georgia
Founded
2011
CLSD Key Statistics
Market Cap
339.63M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
404.46K
High Today
$5.73
Low Today
$5.34
Open Price
$5.52
Volume
408.70K
52 Week High
$7.73
52 Week Low
$1.25
Analyst Ratings
67%
of 6 ratings
Buy
66.7%
Hold
33.3%
Sell
0%
CLSD Earnings
-$0.14
-$0.09
-$0.05
$0.00
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 9, After Hours